According to a new report North America Healthcare CRO Services Market, published by KBV research, the North America Healthcare CRO Services Market would witness market growth of 5.6% CAGR during the forecast period (2019-2025).
The US market dominated the North America Early Phase Development Market by Country 2018, and would continue to be a dominant market till 2025. The Canada market is experiencing a CAGR of 5.4% during (2019 - 2025). Additionally, The Mexico market would witness a CAGR of 7.4% during (2019 - 2025).
The Pharmaceutical Sector market dominated the Canada Healthcare CRO Services Market by End User 2018, growing at a CAGR of 4.8 % during the forecast period. The Medical Device Sector market is witnessing a CAGR of 6.5% during (2019 - 2025). Additionally, The Services market is expected to witness CAGR of 8.6% during (2019 - 2025).
The Oncology market dominated the Mexico Healthcare CRO Services Market by Therapeutic Areas 2018, thereby, achieving a market value of $616.4 million by 2025, growing at a CAGR of 6.5 % during the forecast period. The CNS Disorder market would exhibit a CAGR of 6.8% during (2019 - 2025). The Cardiovascular Disease market is poised to grow at a CAGR of 9% during (2019 - 2025). Additionally, The Diabetes market is expected to witness CAGR of 8.3% during (2019 - 2025).
Report Structural Insights: https://www.kbvresearch.com/north-america-healthcare-cro-services-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.
By Service Type
By End User
By Therapeutic Area
By Country
Companies Profiled
Unique Offerings from KBV Research